ACMS interim decisions
August 24, 2011
THE TGA’s Advisory Committee on
Medicines Scheduling is asking for
further submissions on proposed
scheduling changes for loperamide,
nicotine, orphenadrine and
paracetamol combinations and
cough and cold preparations.
Today the interim decisions and
their reasons for decisions by the
Delegate of the Secretary to the
Department of Health and Ageing
relating to the June 2011 ACMS
meeting have been published on
the TGA website.
The committee has
recommended exempting
loperamide in divided preparations
for oral use containing not more
than 2mg of loperamide in packs of
8 dosage units or less, with the
change to be implemented by 01
May 2012 at the earliest.
The current S4 exemption for
nicotine in preparations for human
therapeutic use is recommended to
be extended to all oralmucosal use,
which harmonises nicotine with
New Zealand scheduling, with an
implementation date of 01 Jan 2012.
The committe also recommended
that the current scheduling of
orphenadrine remain S4, including
when combined with paracetamol.
And following an extensive
review, the committee has
recommended that for cough and
cold preparations the scheduling of
carbetapentane, guaiphenesin,
ipecacuanha, phenylephinre and
senega remain unchanged.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Aug 11To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Aug 11
